Powder: -20°C for 3 years | In solvent: -80°C for 1 year
KPT-251 是一种选择性核输出抑制剂。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,300 | 现货 | ||
5 mg | ¥ 2,920 | 现货 | ||
10 mg | ¥ 4,320 | 现货 | ||
25 mg | ¥ 6,880 | 现货 | ||
50 mg | ¥ 9,330 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 2,990 | 现货 |
产品描述 | KPT-251 is a selective nuclear export inhibitor. |
体外活性 | 在对七种患者来源的GBM线[1]的神经球培养进行KPT-251处理时, 显示出剂量响应性的生长抑制。 |
体内活性 | In a systemic metastasis model, following intracardiac injection of PCb2 cells, 80% (8/10) of controls, 10% (1/10) Selinexor- and 20% (2/10) KPT-251-treated animals developed radiographic evidence of lytic bone lesions. Similarly, after intra-tibial injection, the lytic areas were higher in controls than in Selinexor and KPT-251 groups. Analogously, the serum levels of osteoclast markers (mTRAP and type I collagen fragment, CTX), were significantly higher in controls than in Selinexor- and KPT-251-treated animals. Importantly, overall survival and disease-free survival were significantly higher in Selinexor- and KPT-251-treated animals when compared to controls[2]. |
别名 | KPT251 |
分子量 | 375.23 |
分子式 | C14H7F6N5O |
CAS No. | 1388841-50-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 65 mg/ml (173.23 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.665 mL | 13.3252 mL | 26.6503 mL | 66.6258 mL |
5 mM | 0.533 mL | 2.665 mL | 5.3301 mL | 13.3252 mL | |
10 mM | 0.2665 mL | 1.3325 mL | 2.665 mL | 6.6626 mL | |
20 mM | 0.1333 mL | 0.6663 mL | 1.3325 mL | 3.3313 mL | |
50 mM | 0.0533 mL | 0.2665 mL | 0.533 mL | 1.3325 mL | |
100 mM | 0.0267 mL | 0.1333 mL | 0.2665 mL | 0.6663 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
KPT-251 1388841-50-6 Others myeloid leukemia Apoptosis Chromosomal Maintenance 1 CRM1 inhibit Exportin 1 melanoma XPO1 A375 Inhibitor antileukemic activity KPT 251 KPT251 inhibitor